Human papillomavirus (HPV) type 16 and type 18 antibody concentrations after a single dose of bivalent HPV vaccine in girls aged 9-14 years compared with three doses of quadrivalent HPV vaccine in women aged 18-25 years in Costa Rica (PRIMAVERA): a non-randomised, open-label, immunobridging, non-inferiority trial.

ABSTRACT:

SUBMITTER: Cortes B 

PROVIDER: S-EPMC12630073 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature